Asset Details
Do you wish to reserve the book?
Concomitant serological and molecular methods for 'Strongyloides stercoralis' screening in an endemic area of spain
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Concomitant serological and molecular methods for 'Strongyloides stercoralis' screening in an endemic area of spain
Do you wish to request the book?
Concomitant serological and molecular methods for 'Strongyloides stercoralis' screening in an endemic area of spain
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Concomitant serological and molecular methods for 'Strongyloides stercoralis' screening in an endemic area of spain
2024
Overview
Strongyloidiasis is a widespread parasitic disease that can be life-threatening in immuno-suppressed people. In the Mediterranean basin, autochthonous cases coexist with imported ones. We aimed to assess the utility of different screening methods, along with the frequency of strongy- loidiasis and its associated risk factors in migrants and the native population. This cross-sectional study took place from 2019 to 2022 in the area of the Vega Baja Hospital in Alicante, Spain. Screening was performed in people who were immunosuppressed, at risk of immunosuppression, with blood asymptomatic eosinophilia, and in asymptomatic people from highly endemic countries. Screening methods were serological techniques (ELISA), stool parasitological tests (fecal concentration methods and agar plate culture), and a stool molecular test (PCR). Of the 168 participants (62.5% males, 53.0% migrants, 36.3% immunosuppressed, median age 57 years), 14 (8.3%) had confirmed strongyloidiasis, where 6 were confirmed by serology, 4 by PCR, and 4 by both methods. Overall, 9% of the migrants and 7.6% of the native-born patients were infected. Elevated IgE and hemoglobin and Latin American origin were associated with strongyloidiasis diagnosis. Screening with serology alone would have missed 28.6% of cases. We conclude that strongyloidiasis prevalence is high in our population, both in native and migrant groups, and stool PCR is a useful tool to increase case detection.
Publisher
MDPI,MDPI AG
Subject
/ Disease
/ Enzyme-linked immunosorbent assay
/ HIV
/ Human immunodeficiency virus
/ Methods
/ migrants
/ Patients
/ Serology
/ Steroids
/ Tumors
